# CF Bankshares Inc.: overview CFBK · Nasdaq · CIK 1070680 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/cfbk.md) · [Financials](/companies/cfbk/financials.md) · [Filings](/companies/cfbk/filings.md) · [Insiders](/companies/cfbk/insiders.md) Latest reported revenue: [$146.0k](/filings/0001070680-19-000037.md) for Q3 FY2019, three months to 2019-09-30, from the 10-Q filed Nov 12, 2019 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001070680-19-000037). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.65](/filings/0001193125-25-271208.md) | not reported | [0.68](/filings/0001193125-26-215923.md) | [0.77](/filings/0001193125-26-339475.md) | [0.36](/filings/0001193125-25-271208.md) | not reported | [0.77](/filings/0001193125-26-215923.md) | [0.90](/filings/0001193125-26-339475.md) | | Free cash flow | $m | [(1.3) d](/filings/0001193125-25-271208.md) | [12.4 d](/filings/0001193125-26-103638.md) | [2.2](/filings/0001193125-26-215923.md) | [7.8 d](/filings/0001193125-26-339475.md) | [5.2 d](/filings/0001193125-25-271208.md) | [3.0 d](/filings/0001193125-26-103638.md) | [4.6](/filings/0001193125-26-215923.md) | [5.0 d](/filings/0001193125-26-339475.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.77](/filings/0001070680-24-000006.md) | [2.78](/filings/0001070680-25-000010.md) | [2.63](/filings/0001193125-26-103638.md) | [2.06](/filings/0001193125-26-103638.md) | [2.69](/filings/0001193125-26-103638.md) | | Free cash flow | $m | [250](/filings/0001070680-24-000006.md) | [38.9](/filings/0001070680-25-000010.md) | [17.4](/filings/0001193125-26-103638.md) | [13.9](/filings/0001193125-26-103638.md) | [18.2](/filings/0001193125-26-103638.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cfbk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $12.4m | 377,718 | | Added +67,406 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.9m | 209,107 | | Added +7,106 | | [FIRST MANHATTAN CO. LLC.](/funds/728083.md) | 2026-06-30 | $6.1m | 187,022 | | Unchanged | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $5.6m | 171,288 | | Added +122,387 | | [Fourthstone LLC](/funds/1767803.md) | 2026-06-30 | $5.3m | 159,824 | | Reduced −479,554 | | [Daytona Street Capital LLC](/funds/2101936.md) | 2026-06-30 | $4.8m | 151,386 | | Unchanged | | [Rhino Investment Partners, Inc](/funds/1828776.md) | 2026-06-30 | $4.4m | 135,517 | | Added +10,140 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $4.0m | 123,250 | | Added +31,128 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.9m | 118,800 | | Added +11,793 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $3.9m | 118,575 | | Added +86,054 | ## Recent filings [All 768 filings](/companies/cfbk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-07 | 10:38 ET | [10-Q](/filings/0001193125-26-339475.md) | Quarterly report, period 2026-06-30 | 0001193125-26-339475 | | 2026-07-28 | 09:03 ET | [8-K](/filings/0001193125-26-318995.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318995 | | 2026-05-28 | 09:26 ET | [8-K](/filings/0001193125-26-243166.md) | 5.07 Shareholder vote results | 0001193125-26-243166 | | 2026-05-27 | 08:59 ET | [8-K](/filings/0001193125-26-240626.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-240626 | | 2026-05-11 | 09:43 ET | [10-Q](/filings/0001193125-26-215923.md) | Quarterly report, period 2026-03-31 | 0001193125-26-215923 | | 2026-05-05 | 12:07 ET | [8-K](/filings/0001193125-26-205631.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-205631 | | 2026-04-24 | 11:26 ET | [8-K](/filings/0001193125-26-175963.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-175963 | | 2026-04-23 | 10:21 ET | [DEF 14A](/filings/0001193125-26-172294.md) | Proxy statement, period 2026-04-23 | 0001193125-26-172294 | | 2026-03-26 | 13:44 ET | [8-K](/filings/0001193125-26-125864.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-125864 | | 2026-03-12 | 13:02 ET | [10-K](/filings/0001193125-26-103638.md) | Annual report, period 2025-12-31 | 0001193125-26-103638 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-103638.md), filed Mar 12, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1070680 - Tickers: CFBK - Exchange: Nasdaq - SIC code: 6021 National Commercial Banks - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 09:05 ET. No prices; not investment advice.